Literature DB >> 18058080

[Isolated neuritis of the oculomotor nerve in infectious mononucleosis].

Y Erben1, C Gonzalez Hofmann, H Steinmetz, U Ziemann.   

Abstract

A 19-year-old immune-competent patient developed right-sided headache and, subsequently, subacute diplopia. On clinical examination he had incomplete right oculomotor palsy. Cranial MRI showed pathologic contrast enhancement of the right oculomotor nerve at its exit point from the mesencephalon, and the CSF displayed slight pleocytosis. The following relevant differential diagnoses were not supported by additional examinations: neurosarcoidosis, Lyme neuroborreliosis, neurosyphilis, tuberculous meningitis, viral meningitis (HIV, VZV, CMV), CNS lymphoma, vasculitis associated with rheumatic disease, Tolosa-Hunt syndrome, and diabetic neuropathy. However, on the basis of blood lymphocytosis, positive heterophile antibody test (Paul-Bunnell test), the presence of IgM antibodies against Epstein-Barr virus capsid antigen, and elevated transaminases, infectious mononucleosis was diagnosed. Isolated neuritis of the oculomotor nerve is a rare parainfectious manifestation of infectious mononucleosis.

Entities:  

Mesh:

Year:  2008        PMID: 18058080     DOI: 10.1007/s00115-007-2385-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  11 in total

Review 1.  Epstein-Barr virus and the nervous system.

Authors:  P Portegies; N Corssmit
Journal:  Curr Opin Neurol       Date:  2000-06       Impact factor: 5.710

2.  Miller Fisher syndrome: MRI findings.

Authors:  C A Garcia-Rivera; T D Rozen; D Zhou; P Allahyari; R Niknam; D Dougherty; J Morgan; A Flanders
Journal:  Neurology       Date:  2001-11-27       Impact factor: 9.910

3.  Oculomotor palsy in infectious mononucleosis: case report.

Authors:  M R Watters
Journal:  Mil Med       Date:  1984-01       Impact factor: 1.437

Review 4.  Steroids for symptom control in infectious mononucleosis.

Authors:  B Candy; M Hotopf
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

5.  Isolated cranial nerve III palsy as the presenting manifestation of HIV-related large B-cell lymphoma: clinical, radiological and postmortem observations: report of a case and review of the literature.

Authors:  M Tariq Bhatti; Ilona M Schmalfuss; Thomas A Eskin
Journal:  Surv Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 6.048

6.  Changes of serum angiotensin I converting enzyme in patients with viral hepatitis and liver cirrhosis.

Authors:  H Schweisfurth; H Wernze
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1979-06

7.  MR findings in isolated oculomotor nerve palsy associated with infectious mononucleosis caused by Epstein-Barr virus infection.

Authors:  A Ishibashi; K Sueyoshi; M You; Y Yokokura
Journal:  J Comput Assist Tomogr       Date:  1998 Nov-Dec       Impact factor: 1.826

8.  Cerebrospinal fluid lysozyme and beta 2-microglobulin in neurosarcoidosis.

Authors:  V Oksanen; C Grönhagen-Riska; S Tikanoja; H Somer; F Fyhrquist
Journal:  J Neurol Sci       Date:  1986-03       Impact factor: 3.181

Review 9.  Neurologic complications of infectious mononucleosis.

Authors:  K P Connelly; L D DeWitt
Journal:  Pediatr Neurol       Date:  1994-05       Impact factor: 3.372

Review 10.  B cells under influence: transformation of B cells by Epstein-Barr virus.

Authors:  Ralf Küppers
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

View more
  2 in total

1.  [Proximal radial nerve palsy resulting from acute Epstein-Barr virus infection].

Authors:  A Ring; S Langer; K Harati; H-U Steinau; L Steinstraesser
Journal:  Chirurg       Date:  2011-07       Impact factor: 0.955

2.  Oculomotor Nerve Palsy as a Presenting Symptom of Epstein-Barr Virus-Associated Infectious Mononucleosis: Case Report and Review of the Literature.

Authors:  Leon Amadeus Steiner; Aslihan Erbay; Florence Pache; Moritz Niederschweiberer; Eberhard Siebert; Karen Gertz; Klemens Ruprecht
Journal:  Case Rep Neurol       Date:  2021-11-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.